The additive values of left ventricular function and extent of myocardium at risk to dipyridamole perfusion imaging for optimal risk stratification prior to vascular surgery

Nuclear Medicine Communications

Volumn 20, Issue 10, 1999, Pages 887-894

  Heiba, Sherif I ^a   Sharma, P N ^a   Jacobson, A F ^b   Shattuc, S ^b   Ferreira, M J ^b,c   Cerqueira, M D ^b,d  

^a KUWAIT UNIVERSITY   (Kuwait)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DIPYRIDAMOLE;

ARTICLE; CARDIOVASCULAR RISK; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; IMAGING; MAJOR CLINICAL STUDY; PREOPERATIVE EVALUATION; RISK ASSESSMENT; SURGICAL RISK; VASCULAR SURGERY;

EID: 0032707818     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1080/00006231-199910000-00004     Document Type: Article

References (42)

1. Hertzer N, Beven E, Young J et al. Coronary artery disease in peripheral vascular patients: A classification of 1000 coronary angiograms and results of surgical management. Ann Surg 1984; 199: 223-233.
2. Gersh B, Rihal C, Rooke T, Ballard D. Evaluation and man-agement of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991; 18: 203-214.
3. Hertzer N. Fatal myocardial infarction following lower extremity revascularization: Two hundred seventy-three patients followed six to eleven postoperative years. Ann Surg 1981; 193: 492-498.
4. Jamieson W, Janusz M, Miyagishima R, Gerein A. Influence of ischemic heart disease on early and late mortality after surgery for peripheral occlusive vascular disease. Circulation 1982; 66(suppl. I): 92-97.
5. Thompson J, Hollier L, Patman R, Persson A. Surgical man-agement of abdominal aortic aneurysms: Factors influencing mortality and morbidity. A 20-year experience. Ann Surg 1975; 181: 654-661.
6. Crawford E, Bomberger R, Glaeser D, Saleh S, Russell W. Aortoiliac occlusive disease: Factors influencing survival and function following reconstructive operation over a twenty-five year period. Surgery 1981; 90: 1055-1067.
7. Leppo J. Preoperative cardiac risk assessment for noncardiac surgery. Am J Cardiol 1995; 75: 42D-51D.
8. Boucher C, Brewster D, Darling R, Okada R, Strauss H, Pohost G. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985; 312: 389-394.
9. Eagle K, Singer D, Brewster D, Darling R, Mulley A, Boucher C. Dipyridamole-thallium scanning in patients undergoing vascular surgery. JAMA 1987; 257: 2185-2189.
10. Eagle K, Coley C, Newell J et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Int Med 1989; 110: 859-866.
11. Leppo J, Plaja J, Gionet M, Tumolo J, Paraskos J, Cutler B. Noninvasive evaluation of cardiac risk before elective vascular surgery. J Am Coll Cardiol 1987; 9: 269-276.
12. Brown K, Rowen M. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol 1993; 21: 325-330.
13. Lane S, Lewis S, Pippin J et al. Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus. Am J Cardiol 1989; 64: 1275-1279.
14. Lette J, Waters D, Lapointe J et al. Usefulness of the severity and extent of reversible perfusion defects during thallium-dipyridamole imaging for cardiac risk assessment before noncardiac surgery. Am J Cardiol 1989; 64: 276-281.
15. Levinson J, Boucher C, Coley C, Guiney T, Strauss H, Eagle K. Usefulness of semiquantitative analysis of dipyridamole-thallium-201 redistribution for improving risk stratification before vascular surgery. Am J Cardiol 1990; 66: 406-410.
16. McPhail N, Ruddy T, Calvin J et al. Comparison of left ventricular function and myocardial perfusion for evaluating preoperative cardiac risk of abdominal aortic surgery. Can J Surg 1990; 33: 224-228.
17. Sachs R, Tellier P, Larmignat P et al. Assessment by di-pyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery. Surgery 1988; 103: 584-587.
18. Hachamovitch R, Berman DS, Kiat H et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997; 80: 426-433.
19. Brown K, Boucher C, Okada R et al. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol 1983; 1: 994-1001.
20. Kaul S. Superiority of qualitative exercise thallium-201 variables in determining long-term prognosis in ambulatory patients with chest pain: A comparison with cardiac catheterization. J Am Coll Cardiol 1988; 12: 25-34.
21. Kaul S, Lilly R, Gascho J et al. Prognostic utility of the exercise thallium-201 test in ambulatory patients with chest pain: Comparison with cardiac catheterization. Circulation 1988; 77: 745-758.
22. Pollock S, Abbott R, Boucher C, Beller G, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: Validation of models based on these tests. Circulation 1992; 85: 237-248.
23. Kazmers A, Moneta GL, Cerqueira MD, Healy DA, Zierler RE, Harley JD. The role of preoperative radionuclide ven-triculography in defining outcome after revascularization of the extremity. Surg Gynecol Obstet 1990; 171: 481-488.
24. Pasternack P, Imparato A, Riles T et al. The value of the radionuclide angiogram in the prediction of perioperative myocardial infarction in patients undergoing lower extremity revascularization procedures. Circulation 1985; 72(suppl. II): 13-17.
25. Pasternack P, Imparato A, Bear G et al. The value of radio-nuclide angiography as a predictor of perioperative myocardial infarction in patients undergoing abdominal aortic aneurysm resection. J Vase Surg 1984; 1: 320-325.
26. Matley P, Immelman E, Horak A, Commerford P. Equilibrium radionuclide angiocardiography prior to elective abdominal aortic surgery. Eur J Vase Surg 1991; 5: 187-193.
27. Pedersen T, Kelbaek H, Munck O. Cardiopulmonary com-plications in high-risk surgical patients: The value of pre-operative radionuclide cardiography. Acta Anesthesiol Scand 1990; 34: 183-189.
28. L’ltalien G, Paul S, Hendel R et al. Development and validation of Bayesian model for perioperative cardiac risk assessment in a cohort of 1,081 vascular surgical candidates. J Am Coll Cardiol 1996; 27: 779-786.
29. Heiba SI, Hayat NJ, Salman HS et al. Technetium-99m MIBI myocardial SPECT: Supine versus right lateral imaging and comparison with coronary arteriography. J Nucl Med 1997; 38: 1510-1514.
30. Chin B, Moshin J, Bouchard M, Berlin J, Araujo L, Alavi A. Hemodynamic indices of myocardial dysfunction correlate with dipyridamole thallium-201 SPECT. J Nucl Med 1996; 37: 723-729.
31. Palmas W, Bingham S, Diamond G et al. Incremental prognostic value of exercise thallium-201 myocardial singlephoton emission computed tomography late after coronary artery bypass surgery. J Am Coll Cardiol 1995; 25: 403-409.
32. Cannon R, Dilsizian V, O’Gara P et al. Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy. Circulation 1991; 83: 1660-1667.
33. Hachamovitch R, Berman DS, Shaw LJ et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: Differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998; 97: 535-543.
34. Baron J, Mundler O, Bertrand M et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994; 330: 663-669.
35. Mangano D, London M, Tubau J et al. Dipyridamole thallium-201 scintigraphy as a preoperative screening test: A reexamination of its predictive potential. Circulation 1991; 84: 493-502.
36. Goldman L, Caldera D, Nussbaum S et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977; 297: 845-850.
37. Larson S, Olesen K, Jacobsen E. Prediction of cardiac risk in non-cardiac surgery. Eur Heart J 1987; 8: 179-185.
38. Calvin J, Kieser T, Walley V et al. Cardiac mortality and morbidity after vascular surgery. Can J Surg 1986; 29: 93-97.
39. Cooperman M, Pflug B, Martin EJ, Evans W. Cardiovascular risk factors in patients with peripheral vascular disease. Surgery 1978; 84: 505-509.
40. Detsky A, Abrams H, Forbath N, Scott J, Hilliard J. Cardiac assessment for patients undergoing noncardiac surgery: A multifactorial clinical risk index. Arch Intern Med 1986; 146: 2131-2134.
41. DeBakey M, Lawrie G. Combined coronary artery and peripheral vascular disease: Recognition and treatment. J Vase Surg 1984; 1: 605-607.
42. Raby K, Goldman L, Creager M et al. Correlation between perioperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med 1989; 321: 1296-1300.